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field-in-field (FIFP) plan was addressed by Wilcoxon test. 
Endpoints selected were V95, V105, Maximum Dose within 
PTV, Maximum Dose. 
Results: We analyzed 33 patients. Overall, Patient mean 
setup errors were: Longitudinal (LNG) 4 mm; Lateral (LAT) 3 
mm; Vertical (VRT) 3 mm. 
Values of misalignment of CMF versus FIF during the 
treatment delivery were as follows. Mean: LNG 0.8 (range 0-
6; SD 0.11) mm, LAT 0.6 (range 0-7; SD 0.09) mm, VRT 0.8 
(range 0-6; SD 0.11) mm. Median LNG 0 mm, LAT 0 mm, VRT 
0 mm. A perfect matching of FIF to CMF (i.e. misalignment= 0 
mm) was reported in 52.34% for LNG, 55.47% for LAT and 
50.00% VRT for all analyzed patients overall. Misalignment of 
1 mm was reported in 28.13% for LNG, 35.16% for LAT and 
34.38% for VRT. Misalignment of 2 mm was reported in 
10.16% for LNG, 7.03% for LAT and 10.16% for VRT. 
Misalignment of >3 mm was reported in 9.37% for LNG, 2.34% 
for LAT and 5.47% for VRT. 
The field-in-field plan was significantly superior to the 
conventional tangential one for V95 (p=0.003), Maximum 
Dose within PTV (p=0.033), Maximum Dose (p=0.002); it was 
not significantly superior for V105 (p=0.201) although the 
mean V105 value was overall inferior for the field-in field 
plan (4.01% field-in-field plan vs 4.42% conventional) 
Conclusions: Adjuvant radiotherapy with field-in-field 
technique seems useful to optimize the planning, without 
major drawbacks for the RTT routine practice and presents a 
good geometrical stability during the delivery. The presented 
evaluation, offers, with the collaboration of the RTTs a 
source of information to deepen geometrical, setup and 
planning issues and stimulate the cooperation between 
clinicians, RTT and physics. 
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Purpose/Objective: To investigate the variation in volume, 
position and the target overlap ratio of the oesophageal 
cancer in response to conventional fractioned radiotherapy 
with four-dimensional computed tomography (4D-CT) during 
radiotherapy. 
Materials and Methods: A total of 109 enhanced 4D-CT 
datasets were acquired for 38 patients throughout treatment. 
The gross tumour volumes (GTVs) were delineated on each 
4D-CT dataset, Volumes and coordinates of the GTV and the 
internal gross tumour volume (IGTV) centroids were 
calculated. Trends in magnitudes of intrafraction and 
interfraction positional variations were assessed for the GTV 
and IGTV during treatment. 
Results: The tumour volumes decreased significantly in GTV 
(26.09%, P<0.001) and in IGTV (27.78%, P<0.001) at the 
twentieth fraction, respectively. The intrafraction GTV 
centroid displacements in superior–inferior (SI) direction were 
greater (P<0.001), with median values of 3.1mm, compared 
with 1.6mm and 1.4mm in the right–left (RL) and anterior–
posterior (AP) direction during treatment. However, no 
significant variations were observed in intrafrational GTV 
centroid during radiotherapy in any direction. The IGTV 
centroid displacement in each direction and the 3D vector 
were all<0.8cm, and no significant variations in the centroid 
position were observed for IGTV during radiotherapy. The 
overlap ratios of the targets were decreased for GTV and 
IGTV. 
Conclusions: The variations of GTV centroid displacement 
and IGTV centroid positions were not significant throughout 
treatment. However, the tumour volume decreased 
significantly at the twentieth fraction. The target 
displacement, deformation and regression result in the 
decrease of the overlap ratio relative to the initial target for 
GTV and IGTV. Repeated 4D-CT scans might be beneficial for 
target correction and planning modification.  
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Purpose/Objective: Deep inspiration breath hold (DIBH) 
delivered stereotactic body radiotherapy (SBRT) has been 
shown to be a desirable method of motion management in 
lung tumours. An external fiducial marker can be used as a 
tumour motion surrogate, however, inter-fraction tumour 
motion within DIBH is observed on daily imaging. This study 
evaluates if this motion relates to minor changes in breath 
hold (BH) and the fiducial marker. A secondary aim is to 
evaluate the effect of this motion on surrounding organs at 
risk (OARs). 
Materials and Methods: 121 cone beam computed 
tomography scans (CBCTs) from 22 patients who were treated 
for lung cancer using DIBH SBRT were retrospectively 
evaluated and the magnitude of tumour motion calculated 
for each fraction delivered. This data was analysed to review 
if any correlation was observed between tumour motion and 
variation in the fiducial marker position on the patient, the 
amplitude of BH at planning CT, the amplitude of BH at 
treatment and the tumour location. 
The recorded tumour motion was applied to the original 
planning CT and the plan recalculated to evaluate the 
dosimetric effect on surrounding OARs using cumulative dose 
volume histograms (DVHs). 
Results: It was found that the magnitude of tumour motion 
within BH ranged from 0 to 1.52 cm (0.41 cm ± 0.28 cm 
(mean ± standard deviation)). Motion in the superior-inferior 
(SI), anterior-posterior (AP) and left-right (LR) planes were 
0.31cm ± 0.26 cm, 0.16 cm ± 0.18 cm and 0.07 cm ± 0.12 cm 
respectively. 
No statistically significant correlation was detected between 
tumour motion within DIBH and the factors investigated. The 
range of variation in OAR dose was -7.0Gy to +3.6Gy. The 
chest wall and oesophagus maximum and mean doses were 
